# Cardiokine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardiokine

- Industry: Pharmaceuticals
- Headquarters: Cary, US
- Website: www.cardiokine.com
- Total disclosed funding: $87M
- Latest round: Series B (May 1, 2006)
- Investors on record: 9

## About

Cardiokine, Inc. is a specialty pharmaceutical company, engages in the development of pharmaceuticals for the treatment and prevention of cardiovascular diseases.

## Funding rounds

- Series B, May 1, 2006, $50M — Burrill & Company, Care Capital, HealthCare Ventures, CIBC Capital Partners, Aisling Capital, F-Prime Capital, Teachers' Private Capital, Advent Life Sciences
- Series A, Apr 13, 2004, $37M — Burrill & Company, Care Capital, HealthCare Ventures, Aisling Capital, CIBC

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A, Series B
- Care Capital (https://capitalatlas.ai/funds/care-capital) — Series A, Series B
- HealthCare Ventures — Series A, Series B
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series A, Series B
- CIBC — Series A
- CIBC Capital Partners — Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series B
- Teachers' Private Capital — Series B
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series B
